LD-2 disclosure · 4th Quarter - Report
INFUSION PROVIDERS ALLIANCE
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Healthcare Association
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
LobbyistsBRAD TRAVERSE
Covered position (BRAD TRAVERSE): Former Senior Advisor, Office of the HHS Assistant Secretary of Public Affairs
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS) · Medicare Payment Advisory Commission (MedPAC)
Health Issues
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
LobbyistsBRAD TRAVERSE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)